Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine in Osteoarthritis Knee Pain
NCT00408421Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Nov 2006
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial in osteoarthritis (OA) comparing Duloxetine with Placebo (2 arms). Primary endpoint: Weekly Change From Baseline in the 24-Hour Average Pain Rating Using an 11-Point Numerical Likert Scale Patient Diary at 13 weeks. Started Nov 2006; status: completed.
02
Drugs
duloxetine
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00408421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00408421.